Recent Quarter Total Invested
$2.96 M
Recent Quarter Institutional Ownership Percentage
11.13%
Total Invested of Last Quarter
$1.24 M
Ownership Percentage of Last Quarter
1.76%
Enlivex Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 1.70 M | $2.41 M | 100.00% | 9.08% |
| MORGAN STANLEY | 08/14/2024 | 244,892 | $347,747 | 239.56% | 1.31% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 71,689 | $101,798 | 2.58% | 0.38% |
| XTX TOPCO LTD | 08/12/2024 | 24,820 | $35,244 | 100.00% | 0.13% |
| CITADEL ADVISORS LLC | 08/14/2024 | 16,100 | $22,862 | 7,950.00% | 0.09% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 11,429 | $16,229 | 100.00% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 10,420 | $14,796 | 0.00% | 0.06% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 9,184 | $13,041 | -8.10% | 0.05% |
| GROUP ONE TRADING, L.P. | 08/14/2024 | 5,749 | $8,164 | -20.42% | 0.03% |
| CITADEL ADVISORS LLC | 08/14/2024 | 3,400 | $4,828 | -80.23% | 0.02% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/08/2024 | 3,000 | $4,260 | 0.00% | 0.02% |
| ACTIVEST WEALTH MANAGEMENT | 07/30/2024 | 1,000 | $1,420 | 100.00% | 0.01% |
| SRS CAPITAL ADVISORS, INC. | 08/06/2024 | 615 | $874 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 400 | $568 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 231 | $328 | -96.77% | 0.00% |
| RED TORTOISE LLC | 07/31/2024 | 150 | $213 | 0.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 16 | $23 | -99.48% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 07/23/2024 | 11 | $16 | 100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 1 | $1 | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 07/25/2024 | 0 | $0 | -100.00% | 0.00% |
Enlivex Therapeutics Ltd.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ENLV shares?
During the previous two years, 24 institutional investors and hedge funds held shares of Enlivex Therapeutics Ltd.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 1.7 M
MORGAN STANLEY: 244,892
RENAISSANCE TECHNOLOGIES LLC: 71,689
XTX Topco Ltd: 24,820
GOLDMAN SACHS GROUP INC: 11,429
GEODE CAPITAL MANAGEMENT, LLC: 10,420
-
What percentage of Enlivex Therapeutics Ltd. stock is owned by institutional investors?
11.13% of Enlivex Therapeutics Ltd. stock is owned by institutional investors.
-
How much institutional buying is happening at ENLV ?
Institutional investors have bought a total of 2.10 M shares in the last 24 months. This purchase volume represents approximately $2.64 M in transactions.